Optimal tissue recovery requires coordinated fibroblast activity from deep fascia. Using multi-modal imaging of fascia explants from lineage-specific reporter mice, we tracked wound fibroblasts over 5 days, revealing their organization into supracellular assemblies-sprouting, reticulating, and clustering throughout healing. High-throughput screening of the Prestwick library against these fascia explants identified drugs modulating these behaviors, revealing a spectrum from fibrosis to scarless healing. Recovery phenotypes correlated with fibroblast sprouting, reticulation, and clustering rather than traditional extracellular matrix (ECM) deposition markers. We identified two therapeutic categories: compounds disrupting reticulation/clustering that inhibit scarring and compounds (fluvastatin, thiostrepton, fenbendazole) disrupting sprouting that blocked pro-inflammatory fibroblast/myofibroblast commitment, promoted angiogenesis, reduced inflammatory infiltration, and enabled scar-free regenerative healing with hair follicle papillae regrowth in mice. These findings establish fibroblast supracellular organization as fundamental to tissue recovery, providing novel therapeutic targets for wound healing and fibrotic disorders.
Publishing Place50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
University
University place
Faculty
Publication date0000-00-00
Application number
Application date0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing statusPeer reviewed
Institute(s)Research Unit Signaling and Translation (SAT)
GrantsDeutscher Akademischer Austauschdienst (DAAD) Consejo Nacional de Ciencia y Tecnologia (CONACYT) Jiangxi Province Natural Science Foundation National Natural Science Foundation of China China Scholarship Council Chinese Institutes for Medical Research